
CerebraAI is a healthcare AI company specializing in generative AI solutions for emergency medicine, particularly enhancing the diagnostic capabilities of Non-Contrast CT scans in emergency departments. Their flagship product, CerebraAI Heatmap, uses generative AI to quickly analyze Non-Contrast CT cases to identify brain tissue abnormalities, enabling faster and more accurate stroke diagnosis without the need for contrast agents. The company targets community hospitals and emergency departments globally, with traction including over 50 hospitals, 700 physicians, and 150,000 patients across 3 countries. Founded in 2018, CerebraAI has received multiple awards and recognitions, expanded internationally, and relocated its headquarters to Palo Alto, USA, while preparing for FDA approval. Their business model is primarily SaaS with cloud-native deployment, supporting fast, brand-agnostic CT machine integration.

CerebraAI is a healthcare AI company specializing in generative AI solutions for emergency medicine, particularly enhancing the diagnostic capabilities of Non-Contrast CT scans in emergency departments. Their flagship product, CerebraAI Heatmap, uses generative AI to quickly analyze Non-Contrast CT cases to identify brain tissue abnormalities, enabling faster and more accurate stroke diagnosis without the need for contrast agents. The company targets community hospitals and emergency departments globally, with traction including over 50 hospitals, 700 physicians, and 150,000 patients across 3 countries. Founded in 2018, CerebraAI has received multiple awards and recognitions, expanded internationally, and relocated its headquarters to Palo Alto, USA, while preparing for FDA approval. Their business model is primarily SaaS with cloud-native deployment, supporting fast, brand-agnostic CT machine integration.
Founded: 2018
Headquarters: Palo Alto, California
Product focus: Generative AI for non-contrast CT in emergency medicine (stroke detection)
Traction: +50 hospitals, +700 physicians, +150,000 patients across 3 countries
Business model: SaaS, cloud-native
Emergency medicine / neuroradiology — improving diagnostic value of non-contrast CT scans for stroke detection.
2018
Data and Analytics
Seed round announced October 12, 2023; investors listed include Big Sky Capital, UZCARD Ventures, UMAY Angels Club, Timur Turlov, MOST Ventures, AloqaVentures
7040000
Total funding amount recorded as 7,040,000 USD with last funding date 2024-02-21
“AloqaVentures, Big Sky Capital, Health Engine, MOST Ventures, MedTech Innovator, Quest Ventures, Timur Turlov, UMAY Angels Club, UZCARD Ventures”